Investing

Legend Biotech : LEGN

LEGN

Stock Data

$23.59

$0.07 (0.30%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Legend Biotech Corp is a pioneering biopharmaceutical company focused on creating innovative cell therapies for cancer and other serious diseases. With a leading product candidate aimed at treating multiple myeloma, Legend Biotech is at the forefront of developing chimeric antigen receptor (CAR) T-cell therapies. Their research spans a range of cancers, including leukemia, lymphoma, and various solid tumors. Founded in 2014 and headquartered in Somerset, New Jersey, the company collaborates with Janssen Biotech to advance the reach and effectiveness of its groundbreaking treatments.

All Legend Biotech Articles

1 Article

Lee Jackson | Jan 22, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More

Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back rally across the major indices on…